CWWM
RANI icon

Clear Wave Wealth Management’s Rani Therapeutics RANI Stock Holding History

Clear Wave Wealth Management’s Portfolio RANI Stock Details RANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.1K Hold
13,228
– – ﹤0.01% 191
2026
Q1 		$9.72K Buy
+13,228
New +$16.9K ﹤0.01% 176

Other funds holding RANI

SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LP
Longaeva Partners Chicago, Illinois $4.58B AUM 43.91% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Clear Wave Wealth Management's RANI Position: Q2 2026 in Review

Clear Wave Wealth Management held its Rani Therapeutics (RANI) position steady in Q2 2026 at 13,228 shares worth $10.1K. The position accounts for ﹤0.01% of the portfolio, ranked #191.

Clear Wave Wealth Management first reported a position in RANI in Q1 2026 and has held it in 2 quarters since. 67 funds tracked by Wall St. Rank hold RANI as of Q2 2026.

  • Clear Wave Wealth Management held 13,228 shares of Rani Therapeutics worth $10.1K as of Q2 2026.
  • Clear Wave Wealth Management left its Rani Therapeutics share count unchanged in Q2 2026.
  • Rani Therapeutics made up ﹤0.01% of Clear Wave Wealth Management's portfolio in Q2 2026, its #191 holding.
  • Clear Wave Wealth Management first reported a position in Rani Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 67 funds tracked by Wall St. Rank held Rani Therapeutics as of Q2 2026.

Based on Clear Wave Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.